Global drugmakers Pfizer and BioNTech on Wednesday said that their coronavirus vaccine was found 95 per cent effective in the final analysis of the Phase 3 trial, making way for the companies to secure emergency authorisation from US regulators. Chances are that the vaccine deliveries could start before Christmas.
Global drugmakers Pfizer and BioNTech on Wednesday said that their coronavirus vaccine was found 95 per cent effective in the final analysis of the Phase 3 trial, making way for the companies to secure emergency authorisation from US regulators. Chances are that the vaccine deliveries could start before Christmas. November 19, 2020 at 08:48AM https://ift.tt/2JKxrai
No comments:
Post a Comment